Constanze Cieluch
Rutherford Appleton Laboratory(GB)Humboldt-Universität zu Berlin(DE)Research Complex at Harwell(GB)Freie Universität Berlin(DE)Charité - Universitätsmedizin Berlin(DE)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Inflammatory Bowel Disease, Mesenchymal stem cell research, Inflammasome and immune disorders, Cholinesterase and Neurodegenerative Diseases
Most-Cited Works
- → Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease(2017)772 cited
- → Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease(2017)57 cited
- → Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus(2017)19 cited
- → Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease(2017)16 cited
- → Tissue-infiltrating plasma cells are an important source of carboxylesterase 2 contributing to the therapeutic efficacy of prodrugs(2016)10 cited
- → AB0190 Treatment with Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus